Latest & greatest articles for copd

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on copd or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on copd and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for copd

1. Advanced telehealth technology improves home-based exercise therapy for people with stable chronic obstructive pulmonary disease: a systematic review Full Text available with Trip Pro

University Hospital, Rouen, France; Haute Normandie Research and Biomedical Innovation, Normandy University, Rouen, France. PMID: 33358547 DOI: Item in Clipboard Full text links Cite Display options Display options Format Abstract Questions: How effective is home-based exercise therapy delivered using advanced telehealth technology (ATT-ET) for people with chronic obstructive pulmonary disease (COPD) compared with: no exercise therapy (ET), in/outpatient ET, and home-based ET without ATT? Design (...) Advanced telehealth technology improves home-based exercise therapy for people with stable chronic obstructive pulmonary disease: a systematic review Advanced telehealth technology improves home-based exercise therapy for people with stable chronic obstructive pulmonary disease: a systematic review - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features

2021 EvidenceUpdates

2. NHS Scotland COPD Support Service: remote and self-management of high-risk patients with COPD using a web app and machine learning predictive modelling

and evaluation of the NHSScotland COPD Support Service, which comprises a web app to support remote and self-management of high-risk patients with Chronic Obstructive Pulmonary Disorder (COPD). 1 The local trial and evaluation was carried out by NHS Greater Glasgow and Clyde (NHS GG&C). COPD is a collection of lung diseases including chronic bronchitis, emphysema and chronic obstructive airways disease. 2 People with COPD have difficulties breathing. The web app is intended to promote remote and self (...) of the pathway. References 1. NHSScotland COPD Support Service. NHSScotland COPD Support Service [online]. 2020 [cited 2021 Jan 21]; Available from: https://support.nhscopd.scot/ 2. NHS Inform. Chronic obstructive pulmonary disease [online]. 2019 [cited 2021 Jan 21]. Available from: https://www.nhsinform.scot/illnesses-and-conditions/lungs-and- airways/copd/chronic-obstructive-pulmonary-disease Acknowledgment of professional commentators and fact checking Professional commentary was provided

2021 SHTG Advice Statements

3. Reduced All-Cause Mortality in the ETHOS Trial of Budesonide/Glycopyrrolate/Formoterol for Chronic Obstructive Pulmonary Disease. A Randomized, Double-Blind, Multicenter, Parallel-Group Study Full Text available with Trip Pro

Disease) trial in chronic obstructive pulmonary disease (COPD) ( ), triple therapy with budesonide/glycopyrrolate/formoterol fumarate (BGF) significantly reduced all-cause mortality compared with glycopyrrolate/formoterol fumarate (GFF). However, 384 of 8,509 patients were missing vital status at Week 52 in the original analyses. Objectives: To assess the robustness of the ETHOS mortality findings after additional data retrieval for patients missing Week 52 vital status in the original analyses (...) Free PMC article. No abstract available. References World Health Organization Global health estimates 2016: deaths by cause, age, sex, by country and by region 2000–2016 Geneva, Switzerland: World Health Organization; 2018[updated 2019 Apr 11]. Available from: Global Initiative for Chronic Obstructive Lung Disease 2020 report: global strategy for the diagnosis, management and prevention of COPD Fontana, WI: Gold Initiative for Chronic Obstructive Lung Disease; 2020[updated 2020 Mar 17]. Available

2021 EvidenceUpdates

4. Formoterol fumarate dihydrate/glycopyrronium/budesonide (Trixeo Aerosphere) - adult patients with moderate to severe chronic obstructive pulmonary disease (COPD)

Formoterol fumarate dihydrate/glycopyrronium/budesonide (Trixeo Aerosphere) - adult patients with moderate to severe chronic obstructive pulmonary disease (COPD) Published 08 February 2021 1 Product update SMC2321 formoterol fumarate dihydrate / glycopyrronium / budesonide 5mcg/7.2mcg/160mcg pressurised inhalation, suspension (Trixeo® Aerosphere) AstraZeneca 15 January 2021 The Scottish Medicines Consortium (SMC) has completed its assessment of the above product and, following review by the SMC (...) executive, advises NHS Boards and Area Drug and Therapeutics Committees (ADTCs) on its use in NHSScotland. The advice is summarised as follows: ADVICE: following an abbreviated submission formoterol fumarate dihydrate / glycopyrronium / budesonide (Trixeo® Aerosphere) is accepted for restricted use within NHSScotland. Indication under review: maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (COPD) who are not adequately treated by a combination

2021 Scottish Medicines Consortium

5. Formoterol / glycopyrronium bromide / budesonide (Trixeo Aerosphere) - chronic obstructive pulmonary disease (COPD)

EMEA/H/C/004983 Trixeo Aerosphere (formoterol / glycopyrronium bromide / budesonide) An overview of Trixeo Aerosphere and why it is authorised in the EU What is Trixeo Aerosphere and what is it used for? Trixeo Aerosphere is a medicine used to treat patients with moderate to severe chronic obstructive pulmonary disease (COPD), a long-term disease in which the airways and air sacs in the lungs become damaged or blocked, leading to difficulty breathing. Trixeo Aerosphere is used for maintenance (...) Formoterol / glycopyrronium bromide / budesonide (Trixeo Aerosphere) - chronic obstructive pulmonary disease (COPD) Official address Domenico Scarlattilaan 6 ? 1083 HS Amsterdam ? The Netherlands Address for visits and deliveries Refer to www.ema.europa.eu/how-to-find-us Send us a question Go to www.ema.europa.eu/contact Telephone +31 (0)88 781 6000 An agency of the European Union © European Medicines Agency, 2021. Reproduction is authorised provided the source is acknowledged. EMA/561272/2020

2021 European Medicines Agency - EPARs

6. Association of beta-blocker use with survival and pulmonary function in patients with chronic obstructive pulmonary and cardiovascular disease: a systematic review and meta-analysis Full Text available with Trip Pro

Share Permalink Copy Page navigation Eur Heart J Actions . 2020 Nov 19;ehaa793. doi: 10.1093/eurheartj/ehaa793. Online ahead of print. Association of β-blocker use with survival and pulmonary function in patients with chronic obstructive pulmonary and cardiovascular disease: a systematic review and meta-analysis , , , , , Affiliations Expand Affiliations 1 Department of Respiratory and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union (...) with chronic obstructive pulmonary and cardiovascular disease: a systematic review and meta-analysis Yan-Li Yang et al. Eur Heart J . 2020 . Show details Display options Display options Format Eur Heart J Actions . 2020 Nov 19;ehaa793. doi: 10.1093/eurheartj/ehaa793. Online ahead of print. Authors , , , , , Affiliations 1 Department of Respiratory and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, No. 1 Shuai Fu Yuan, Dong

2020 EvidenceUpdates

7. Elastic Resistance Training Produces Benefits Similar to Conventional Resistance Training in People With Chronic Obstructive Pulmonary Disease: Systematic Review and Meta-Analysis

was to investigate the effectiveness of elastic resistance training on improving muscle strength, functional exercise capacity, health-related quality of life (HRQoL), and dyspnea in people with stable chronic obstructive pulmonary disease (COPD). Methods: For this systematic review, PubMed, The Cochrane Library, Embase (OVID), PEDro, SciELO, and CINAHL were searched from inception to November 2019. Included studies were randomized clinical trials in which people with stable COPD were allocated to (1 (...) : Training with elastic resistance tubes or bands-which are easy to carry, easy to use, and relatively low cost-can be an effective way to improve strength for people with COPD and promote similar benefits to those achieved with weight machines. Keywords: Chronic Obstructive Pulmonary Disease; Exercise; Muscle Strength; Rehabilitation. © The Author(s) 2020. Published by Oxford University Press on behalf of the American Physical Therapy Association. All rights reserved. For permissions, please email

2020 EvidenceUpdates

8. A mobile health application to support self-management in patients with chronic obstructive pulmonary disease: a randomised controlled trial

The Third Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China. PMID: 32907384 DOI: Item in Clipboard Full-text links Cite Display options Display options Format Abstract Objective: To investigate the effects of a mobile health smartphone application to support self-management programmes on quality of life, self-management behaviour and exercise and smoking cessation behaviour in patients with chronic obstructive pulmonary disease (COPD). Design: A randomised controlled, single-blind (...) participants' exercise and smoking cessation behaviour. Conclusions: The mobile health smartphone application to support self-management programmes was effective in improving health-related quality of life and self-management behaviour in patients with COPD. Trial registration: This study was registered in Chinese clinicaltrials.gov. Keywords: Chronic obstructive pulmonary disease; mobile health application; randomised control trial; self-management. Similar articles McCabe C, McCann M, Brady AM. McCabe C

2020 EvidenceUpdates

9. Endobronchial valves for lung volume reduction in patients with severe or very severe emphysema

pulmonary disease (COPD) are chronic, progressive, and ultimately fatal, diseases of the lungs. Emphysema is one of two conditions that are classed as COPD, the other being chronic bronchitis. Emphysema can exist without chronic bronchitis as a distinct respiratory condition. Patients with COPD can have predominantly emphysema, predominantly chronic bronchitis, or both. Chronic obstructive pulmonary disease is the second most common lung disease in the UK. Treatments for emphysema/COPD include lifestyle (...) Apr 23]; Available from: https://www.mayoclinic.org/diseases-conditions/pneumothorax/symptoms-causes/syc- 20350367. 4. British Lung Foundation. COPD (chronic obstructive pulmonary disease): emphysema. 2020 [cited 2020 Apr 23]; Available from: https://www.blf.org.uk/support-for- you/copd/emphysema. 5. Cetti EJ, Moore AJ, Geddes DM. Collateral ventilation. Thorax. 2006;61(5):371-3. 6. MedlinePlus. Subcutaneous emphysema. 2020 [cited 2020 May 07]; Available from: https://medlineplus.gov/ency/article

2020 SHTG Advice Statements

10. Effects of downhill walking in pulmonary rehabilitation for patients with COPD: a randomised controlled trial Full Text available with Trip Pro

rehabilitation for patients with COPD: a randomised controlled trial , , , , , , , , , , , Affiliations Expand Affiliations 1 Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Department of Chronic Diseases, Metabolism and Ageing (CHROMETA), KU Leuven, Leuven, Belgium. 2 University Pitágoras UNOPAR, Department of Rehabilitation Sciences, Londrina, Brazil. 3 Both authors contributed equally. 4 Monash University, Department of Physiotherapy, Victoria, Australia. 5 Monash Health, Monash Lung (...) , Belgium thierry.troosters@kuleuven.be. PMID: 32444407 DOI: Item in Clipboard Full-text links Cite Display options Display options Format Abstract The development of contractile muscle fatigue (CMF) affects training responses in patients with chronic obstructive pulmonary disease (COPD). Downhill walking induces CMF with lower dyspnoea and fatigue than level walking. This study compared the effect of pulmonary rehabilitation (PR) comprising downhill walking training (DT) to PR comprising level walking

2020 EvidenceUpdates

11. Short physical performance battery as a practical tool to assess mortality risk in chronic obstructive pulmonary disease Full Text available with Trip Pro

, Cambridge Institute of Public Health, University of Cambridge, Cambridge, UK. 14 Alan Turing Institute, London, UK. 15 Cambridge Clinical Trials Unit, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Cambridge, UK. 16 Department of Respiratory Medicine, Royal Brompton Hospital, London, UK. PMID: 32894757 DOI: Item in Clipboard Short physical performance battery as a practical tool to assess mortality risk in chronic obstructive pulmonary disease Jilles M Fermont et al. Age (...) Short physical performance battery as a practical tool to assess mortality risk in chronic obstructive pulmonary disease Short physical performance battery as a practical tool to assess mortality risk in chronic obstructive pulmonary disease - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging, rapidly evolving

2020 EvidenceUpdates

12. Effect of Sustained-Release Morphine for Refractory Breathlessness in Chronic Obstructive Pulmonary Disease on Health Status: A Randomized Clinical Trial

: DOI: Item in Clipboard Full-text links Cite Display options Display options Format Abstract Importance: Morphine is used as palliative treatment of chronic breathlessness in patients with advanced chronic obstructive pulmonary disease (COPD). Evidence on respiratory adverse effects and health status is scarce and conflicting. Objective: To assess the effects of regular, low-dose, oral sustained-release morphine on disease-specific health status (COPD Assessment Test; CAT), respiratory outcomes (...) Effect of Sustained-Release Morphine for Refractory Breathlessness in Chronic Obstructive Pulmonary Disease on Health Status: A Randomized Clinical Trial Effect of Sustained-Release Morphine for Refractory Breathlessness in Chronic Obstructive Pulmonary Disease on Health Status: A Randomized Clinical Trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features

2020 EvidenceUpdates

13. Randomized Trial of Nocturnal Oxygen in Chronic Obstructive Pulmonary Disease. (Abstract)

Randomized Trial of Nocturnal Oxygen in Chronic Obstructive Pulmonary Disease. Long-term oxygen therapy improves survival in patients with chronic obstructive pulmonary disease (COPD) and chronic severe daytime hypoxemia. However, the efficacy of oxygen therapy for the management of isolated nocturnal hypoxemia is uncertain.We designed this double-blind, placebo-controlled, randomized trial to determine, in patients with COPD who have nocturnal arterial oxygen desaturation without qualifying (...) for long-term oxygen therapy, whether nocturnal oxygen provided for a period of 3 to 4 years would decrease mortality or the worsening of disease such that patients meet current specifications for long-term oxygen therapy. Patients with an oxygen saturation of less than 90% for at least 30% of the recording time on nocturnal oximetry were assigned, in a 1:1 ratio, to receive either nocturnal oxygen or ambient air from a sham concentrator (placebo). The primary outcome was a composite of death from any

2020 NEJM

14. The effect of acupoint application of traditional Chinese medicine for the treatment of chronic obstructive pulmonary disease: a protocol for systematic review and meta-analysis Full Text available with Trip Pro

The effect of acupoint application of traditional Chinese medicine for the treatment of chronic obstructive pulmonary disease: a protocol for systematic review and meta-analysis Inplasy Protocol 751 - INPLASY.COM International Platform of Registered Systematic Review and Meta-analysis Protocols Main Menu Share this: Copyright © 2021 INPLASY.COM Powered by INPLASY.COM

2020 INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols

15. myCOPD for self-management of chronic obstructive pulmonary disease

to the clinical effectiveness of the technology. Further information about how the evidence for this briefing was selected is available on request by contacting mibs@nice.org.uk. Published evidence Published evidence Three studies are summarised in this briefing, including 2 randomised controlled trials and 1 observational study. In total, there were 167 people with chronic obstructive pulmonary disease (COPD) in these studies. The clinical evidence and its strengths and limitations is summarised (...) myCOPD for self-management of chronic obstructive pulmonary disease myCOPD for self-management of chronic obstructive pulmonary disease Medtech innovation briefing Published: 1 April 2020 www.nice.org.uk/guidance/mib214 pathways Summary Summary • The technology technology described in this briefing is myCOPD. It helps people with chronic obstructive pulmonary disease (COPD) to manage their symptoms and reduce the number of healthcare visits they need. It also helps the healthcare professionals

2020 NICE COVID-19 rapid evidence summary

16. Proton pump inhibitors for chronic obstructive pulmonary disease. (Abstract)

Proton pump inhibitors for chronic obstructive pulmonary disease. Chronic obstructive pulmonary disease (COPD) is a common and progressive disease characterised by chronic cough, airflow limitation and recurrent exacerbations. Since COPD exacerbations are linked to rising mortality and reduced quality of life, the condition poses a substantial burden on individuals, society and the healthcare system. Effective management of COPD exacerbations that includes treatment of related conditions (...) COPD exacerbations, pneumonia and other serious adverse events. Secondary outcomes were quality of life, lung function test indices, acute respiratory infections and disease-specific adverse events. We extracted data on these outcome measures and entered into them into Review Manager software for analysis.The search identified 99 records, and we included one multicentre RCT that randomised 103 adults with COPD. The 12-month RCT compared an oral PPI (lansoprazole) and usual care versus usual care

2020 Cochrane

17. Chronic Obstructive Pulmonary Disease. (Abstract)

Chronic Obstructive Pulmonary Disease. Chronic obstructive pulmonary disease (COPD) is characterized by persistent respiratory symptoms and progressive airflow obstruction. Tobacco smoking is the leading cause but not the only one. A postbronchodilator FEV1-FVC ratio less than 0.70 is required for a diagnosis of COPD. Inhaler therapy is the backbone of treatment and should be complemented by a multifaceted management strategy that includes counseling and pharmacotherapy for smoking cessation (...) , pulmonary rehabilitation, treatment of comorbidities, administration of influenza and pneumococcal immunizations, and prescription of long-term oxygen therapy in hypoxemic patients.

2020 Annals of Internal Medicine

18. Protocol for an updated systematic review and meta-analysis of prevalence of cognitive impairment in COPD patients Full Text available with Trip Pro

Protocol for an updated systematic review and meta-analysis of prevalence of cognitive impairment in COPD patients Inplasy Protocol 584 - INPLASY.COM International Platform of Registered Systematic Review and Meta-analysis Protocols Main Menu Share this: Copyright © 2021 INPLASY.COM Powered by INPLASY.COM

2020 INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols

19. Chronic obstructive pulmonary disease (COPD) is associated with a higher level of serum uric acid. A systematic review and meta-analysis Full Text available with Trip Pro

Chronic obstructive pulmonary disease (COPD) is associated with a higher level of serum uric acid. A systematic review and meta-analysis Chronic obstructive pulmonary disease (COPD) is associated with a higher level of serum uric acid. A systematic review and meta-analysis | Wattanachayakul | Advances in Respiratory Medicine MENU Shortcuts Open Journal Systems open access Vol 88, No 3 (2020) Research paper Published online: 2020-07-18 Submitted: 2019-12-28 Accepted: 2020-03-15 Get Citation BIB (...) with chronic obstructive pulmonary disease (COPD) may have a higher level of serum uric acid compared with individuals without COPD, although the data are still limited. The current systematic review and meta-analysis was conducted to summarize all available data. Material and methods: A systematic review was performed using the MEDLINE and EMBASE databases from their inception to July 2019. Studies that were eligible for the meta-analysis must have consisted of two groups of participants, patients

2020 Advances in respiratory medicine

20. Effects of exercise interventions on respiratory drive (Emgdi%max) in patients with chronic obstructive pulmonary disease: a Systematic Review and Meta-Analysis Full Text available with Trip Pro

Effects of exercise interventions on respiratory drive (Emgdi%max) in patients with chronic obstructive pulmonary disease: a Systematic Review and Meta-Analysis Inplasy Protocol 485 - INPLASY.COM International Platform of Registered Systematic Review and Meta-analysis Protocols Main Menu Share this: Copyright © 2021 INPLASY.COM Powered by INPLASY.COM

2020 INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols